Use of cholecystokinin pancreozymin in treatment of some pancreobiliary system diseases
Darmostuk, V.I.
Vrachebnoe Delo 5: 28-32
1977
ISSN/ISBN: 0049-6804 PMID: 878412 Document Number: 113839
Document emailed within 1 workday
Related Documents
Iwata, Y.; Arakawa, T.; Kuroki, T.; Kobayashi, K. 1999: Cholecystokinin.pancreozymin (CCK-PZ) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 332-334Schlegel, W.; Grube, D. 1978: Radioimmunoassay [RIA] of cholecystokinin-pancreozymin [33-CCK Zeitschrift für Gastroenterologie 16(5): 304-310
Geller, L.I. 1976: Clinical pharmacology of cholecystokinin--pancreozymin Klinicheskaia Meditsina 54(3): 23-29
Holtermüller, K.H.; McCall, J.T.; Malagelada, J.R.; Go, V.L. 1974: Intraduodenal calcium stimulates liberation of cholecystokinin-pancreozymin (CCK-PZ) in man Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 536-537
Kanno, T.; Saito, A.; Yonezawa, H. 1980: Unidirectional cellular processes of stimulus-secretion coupling in a cell secreting cholecystokinin-pancreozymin Advances in Biochemical Psychopharmacology 25: 327-332
Loginov, A.S.; Goriacheva, T.V. 1982: Participation of cGMP in realizing the effect of cholecystokinin-pancreozymin on the bile-excreting function of the human liver Biulleten' Eksperimental'noi Biologii i Meditsiny 94(8): 8-11
Batt, R.A. 1983: Decreased food intake in response to cholecystokinin (pancreozymin) in wild-type and obese mice (genotype ob/ob) International Journal of Obesity 7(1): 25-29
Lankisch, P.G.; Fölsch, U.R.; Köstering, H.; Creutzfeldt, W. 1976: Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction induced by secretin, cholecystokinin-pancreozymin and carbachol administration Zeitschrift für Gastroenterologie. Verhandlungsband 10: 51-55
Rodriguez, M.; Lignon, M.F.; Galas, M.C.; Amblard, M.; Martinez, J. 1990: Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors Molecular Pharmacology 38(3): 333-341
Lilja, P.; Fagan, C.J.; Wiener, I.; Inoue, K.; Watson, L.C.; Rayford, P.L.; Thompson, J.C. 1982: Infusion of pure cholecystokinin in humans. Correlation between plasma concentrations of cholecystokinin and gallbladder size Gastroenterology 83(1 Pt 2): 256-261
Wiśniewska, R.J. 1998: Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A Polish Journal of Pharmacology 50(3): 203-212
Khodos, K.G.; Kondakova, T.A. 1978: Analysis of pathoanatomic data at Irkutsk Clinic for nervous system Diseases on infectious diseases of the nervous system over 20-year period (1956--75) Klinicheskaia Meditsina 56(9): 84-88
Adamenko, R.I. 1989: Herbal treatment in nervous system diseases Fel'dsher i Akusherka 54(8): 47-49
Barla Szabó, S. 1979: Treatment of diseases of the locomotor system and cooperation of specialists Orvosi Hetilap 120(52): 3203
Kuzin, E.M. 1977: Use of hydrocortisone for treatment of diseases of the support-locomotor system Vestnik Khirurgii Imeni I. I. Grekova 118(1): 64-66
Kartashevskiĭ, N.G.; Senchilo, E.A. 1971: Our experience in the surgical treatment of diseases of the blood system Problemy Gematologii i Perelivaniia Krovi 16(11): 7-11
Pantazopoulos, P.; Coyas, A.; Papafrangos, C.; Dokianakis, G. 1971: Deafness in central nervous system diseases and their treatment Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 88(4): 229-232
Zakomernyĭ, A.G. 1991: Staged treatment of children with digestive system diseases Pediatriia 9: 69-73
Szulc, E.J. 1977: Perclusone in the treatment of inflammatory and degenerative diseases of the locomotor system Wiadomosci Lekarskie 30(2): 93-95
Kuliev, R.A. 1992: Vacuum fixation of the drainage system during the treatment of suppurative diseases Klinicheskaia Khirurgiia 1: 59